V
Vaccinex
VCNX
4.84000
USD
-0.27
(-5.28%)
مغلق
حجم التداول
223
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
7,071,260
العنوان: Vaccinex
القطاع: Healthcare
الصناعة: Biotechnology
Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. The firm has also developed a proprietary drug discovery platform, ActivMAb.